You searched for metabolic diseases - Page 47 of 62

In Depth 6 May 2025

The future of diabetes treatment: Is a cure possible?

…to multiple chronic diseases, including diabetes. Recent studies have explored interventions aimed at modulating the gut microbiota to improve glycemic control. For instance, fecal microbiota transplantation (FMT) has been investigated…

May 6, 2025 - 11 minutesmins - By Jules Adam

News and Trends 13 Aug 2018

Orchard Therapeutics Raises €132M to Develop Gene Therapies

…most advanced clinical programs, which aim to treat rare inherited metabolic and immune system diseases. The news follows Orchard’s acquisition of GSK’s entire gene therapy portfolio last year, including Strimvelis,…

August 13, 2018 - 2 minutesmins - By Alexander Burik

Orchard therapeutics gene therapy header

News and Trends 23 Apr 2020

Sofinnova Invests €20M in Three Italian Rare Disease Biotechs

…treatments to tackle a range of rare genetic diseases such as inflammatory skin conditions and metabolic disorders. Genespire received €16M of the funding, though the precise amounts received by the…

April 23, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 18 Apr 2017

Two Big Pharma Players Team up to Take Over the NASH Space

…compounds attack the metabolic stages of NASH and as Marco Boorsma, a partner at Forbion Partners told us in our recent NASH review: FXR has been a target of great…

April 18, 2017 - 3 minutesmins - By Melanie De Almeida

In Depth 27 Jun 2024

The 2024 drug approval list: Eight new treatments you should know about

…the potentially life-threatening liver condition metabolic dysfunction-associated steatohepatitis (MASH), Rezdiffra received the green light from the U.S. Food and Drug Administration (FDA) to treat the disease back in March. MASH…

June 27, 2024 - 9 minutesmins - By Roohi Mariam Peter

In Depth 2 Nov 2023

How French pharma giant Sanofi is betting big on AI

…drugs for metabolic diseases, before Sanofi then in-licensed one of the candidates in 2019. As it turned out, 2022 brought with it three more major AI deals for Sanofi. These…

November 2, 2023 - 8 minutesmins - By Willow Shah-Neville

News and Trends 20 Mar 2017

French Biotech fails Second Phase II Trial for Cardiovascular Disease

…cardiovascular and metabolic diseases. The company now presented data on its lead candidate CER-001, which was investigated in a Phase II study for the treatment of patients with post-acute coronary…

March 20, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 11 Jan 2022

Sanofi Joins AI Gold Rush in €4.6B Drug Discovery Pact with Exscientia

…of bispecific small molecule drugs for metabolic diseases, with Sanofi in-licensing one of the candidates in 2019. As part of the new deal, Exscientia will screen patient tissue data with…

January 11, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 20 Jan 2023

Brenus Pharma and InSphero bag €1.5M for next-generation cancer cell immunotherapy

…discovery and safety testing. The company specializes in liver toxicology, metabolic diseases (e.g., T1 & T2 diabetes and NAFLD & NASH liver disease), and oncology (with a focus on immuno-oncology…

January 20, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 20 Jan 2023

DeuterOncology closes financing round to start lung cancer study

…overcomes this at source, having a metabolically-liable hydrogen replaced with a stronger bond strength deuterium atom. This significantly reduces the impact of this metabolic liability during treatment. The strength of…

January 20, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 19 Oct 2017

Meet some of the Hottest Startups of 2017!

…covering neuroscience, oncology, cardiovascular and metabolic diseases, immunology, infectious diseases, vaccines and pulmonary hypertension. Chosen startups will have the opportunity to present their innovative ideas to a panel of expert…

October 19, 2017 - 7 minutesmins - By External Contributor

News and Trends 9 May 2017

AI-Based Drug Discovery Biotech is Recruited by Sanofi in €250M Deal

…believes using a bispecific drug approach that goes after more than one target can significantly increase the chances of success. Especially in metabolic diseases with high complexity such as diabetes….

May 9, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

The future of diabetes treatment: Is a cure possible?

Orchard Therapeutics Raises €132M to Develop Gene Therapies

Sofinnova Invests €20M in Three Italian Rare Disease Biotechs

Two Big Pharma Players Team up to Take Over the NASH Space

The 2024 drug approval list: Eight new treatments you should know about

How French pharma giant Sanofi is betting big on AI

French Biotech fails Second Phase II Trial for Cardiovascular Disease

Sanofi Joins AI Gold Rush in €4.6B Drug Discovery Pact with Exscientia

Brenus Pharma and InSphero bag €1.5M for next-generation cancer cell immunotherapy

DeuterOncology closes financing round to start lung cancer study

Meet some of the Hottest Startups of 2017!

AI-Based Drug Discovery Biotech is Recruited by Sanofi in €250M Deal

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!